Drug makers are getting closer to making effective migraine treatments.
Several therapies in late-stage development attack a chemical called calcitonin gene-related peptide (CGRP), which is a protein found in nerves and embedded in blood vessels. Studies have shown CGRP can signal pain when the chemical enters the blood stream or appears between nerves, but can also serve as a migraine trigger too in certain patients.
Read more at Drug Discovery & Development
Filed Under: Drug Discovery